Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Income Before Tax

Profit after all operating and non-operating items but before income tax.

No reported Income Before Tax figures are available to summarize.

Income Before Tax history

Currency unavailable · from the income statement

No Income Before Tax data reported for this period type.

Income Before Tax vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Income Before Tax for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IKTInhibikase Therapeutics, Inc.LTM Mar 2026-$50.96M USD-39.4%——
RNAAtrium Therapeutics, Inc.FY2025-$76.83M USD——412.6%
TNYATenaya Therapeutics, Inc.LTM Mar 2026-$83.01M USD+21.5%—36891.1%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026-$259.5M USD-56.6%—3644.2%
CYTKCytokinetics, IncorporatedLTM Jun 2026-$894M USD-47.4%—1259.9%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-43.4%—2452.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.